国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
14期
2085-2089
,共5页
杜培%张晓薇%陈礼全%陈国勤
杜培%張曉薇%陳禮全%陳國勤
두배%장효미%진례전%진국근
卵巢上皮性癌%CA125%Ki67
卵巢上皮性癌%CA125%Ki67
란소상피성암%CA125%Ki67
Ovarian epithelial Carcinoma%CA125%Ki67
目的 探讨CA125和Ki67在卵巢上皮性癌组织中的表达及与卵巢上皮性癌临床病理学特征的关系,探讨两者之间的相关性,并与血清中CA125的表达进行分析比较.方法 采用免疫组织化学SP法检测CA125和Ki6在58例卵巢上皮性癌组织中的表达,用电化学发光法检测血清中CA125的水平.结果 CA125在卵巢浆乳癌、黏液性癌、透明细胞癌及内膜样癌中的阳性率分别为84.62%、33.33%、66.67%和71.43%,浆乳癌的阳性表达率最高,黏液性癌的阳性表达率最低,浆乳癌vs黏液性癌,差异有统计学意义(P<0.01);CA125在卵巢上皮癌中-低分化组的阳性率(80.00%)高于高分化组(53.85%),但无统计学意义(P>0.05);晚期患者(Ⅲ~Ⅳ期)的阳性率(85.71%)显著高于早期患者(Ⅰ~Ⅱ期)(56.52%)(P<0.05).Ki67在浆乳癌、黏液性癌、透明细胞癌及内膜样癌中的高表达率分别为76.92%、77.78%、100%和71.43%,差异无统计学意义(P>0.05);Ki67在卵巢上皮癌中-低分化组的高表达率(86.67%)显著高于高分化组(46.15%)(P< 0.01);在晚期患者(Ⅲ~Ⅳ期)的高表达率(88.57%)显著高于早期患者(Ⅰ~Ⅱ期)(60.87%)(P<0.05).在卵巢浆乳癌患者组织中CA125和Ki67之间的表达呈正相关(P<0.01).在卵巢浆乳癌患者血清中的CA125浓度与组织中CA125和Ki67的表达呈正相关(P<0.05).结论 CA125和Ki67与卵巢上皮性癌的分化、分级、转移密切相关,卵巢浆乳癌的血清CA125水平与组织的CA125和Ki67表达密切相关,联合检测浆乳癌组织CA125和Ki67的表达水平及血清CA125的浓度,对评估卵巢浆乳癌患者的恶性程度、转移等生物学行为及预后较单独检测更具有实际意义.
目的 探討CA125和Ki67在卵巢上皮性癌組織中的錶達及與卵巢上皮性癌臨床病理學特徵的關繫,探討兩者之間的相關性,併與血清中CA125的錶達進行分析比較.方法 採用免疫組織化學SP法檢測CA125和Ki6在58例卵巢上皮性癌組織中的錶達,用電化學髮光法檢測血清中CA125的水平.結果 CA125在卵巢漿乳癌、黏液性癌、透明細胞癌及內膜樣癌中的暘性率分彆為84.62%、33.33%、66.67%和71.43%,漿乳癌的暘性錶達率最高,黏液性癌的暘性錶達率最低,漿乳癌vs黏液性癌,差異有統計學意義(P<0.01);CA125在卵巢上皮癌中-低分化組的暘性率(80.00%)高于高分化組(53.85%),但無統計學意義(P>0.05);晚期患者(Ⅲ~Ⅳ期)的暘性率(85.71%)顯著高于早期患者(Ⅰ~Ⅱ期)(56.52%)(P<0.05).Ki67在漿乳癌、黏液性癌、透明細胞癌及內膜樣癌中的高錶達率分彆為76.92%、77.78%、100%和71.43%,差異無統計學意義(P>0.05);Ki67在卵巢上皮癌中-低分化組的高錶達率(86.67%)顯著高于高分化組(46.15%)(P< 0.01);在晚期患者(Ⅲ~Ⅳ期)的高錶達率(88.57%)顯著高于早期患者(Ⅰ~Ⅱ期)(60.87%)(P<0.05).在卵巢漿乳癌患者組織中CA125和Ki67之間的錶達呈正相關(P<0.01).在卵巢漿乳癌患者血清中的CA125濃度與組織中CA125和Ki67的錶達呈正相關(P<0.05).結論 CA125和Ki67與卵巢上皮性癌的分化、分級、轉移密切相關,卵巢漿乳癌的血清CA125水平與組織的CA125和Ki67錶達密切相關,聯閤檢測漿乳癌組織CA125和Ki67的錶達水平及血清CA125的濃度,對評估卵巢漿乳癌患者的噁性程度、轉移等生物學行為及預後較單獨檢測更具有實際意義.
목적 탐토CA125화Ki67재란소상피성암조직중적표체급여란소상피성암림상병이학특정적관계,탐토량자지간적상관성,병여혈청중CA125적표체진행분석비교.방법 채용면역조직화학SP법검측CA125화Ki6재58례란소상피성암조직중적표체,용전화학발광법검측혈청중CA125적수평.결과 CA125재란소장유암、점액성암、투명세포암급내막양암중적양성솔분별위84.62%、33.33%、66.67%화71.43%,장유암적양성표체솔최고,점액성암적양성표체솔최저,장유암vs점액성암,차이유통계학의의(P<0.01);CA125재란소상피암중-저분화조적양성솔(80.00%)고우고분화조(53.85%),단무통계학의의(P>0.05);만기환자(Ⅲ~Ⅳ기)적양성솔(85.71%)현저고우조기환자(Ⅰ~Ⅱ기)(56.52%)(P<0.05).Ki67재장유암、점액성암、투명세포암급내막양암중적고표체솔분별위76.92%、77.78%、100%화71.43%,차이무통계학의의(P>0.05);Ki67재란소상피암중-저분화조적고표체솔(86.67%)현저고우고분화조(46.15%)(P< 0.01);재만기환자(Ⅲ~Ⅳ기)적고표체솔(88.57%)현저고우조기환자(Ⅰ~Ⅱ기)(60.87%)(P<0.05).재란소장유암환자조직중CA125화Ki67지간적표체정정상관(P<0.01).재란소장유암환자혈청중적CA125농도여조직중CA125화Ki67적표체정정상관(P<0.05).결론 CA125화Ki67여란소상피성암적분화、분급、전이밀절상관,란소장유암적혈청CA125수평여조직적CA125화Ki67표체밀절상관,연합검측장유암조직CA125화Ki67적표체수평급혈청CA125적농도,대평고란소장유암환자적악성정도、전이등생물학행위급예후교단독검측경구유실제의의.
Objective To investigate the expression of CA 125 and Ki67 in ovarian epithelial carcinoma and its relationship with clinical pathological features of ovarian epithelial carcinoma,to explore the correlation between the two and carry on the analysis and comparison with serum CAl25 expression.Methods Used immunohistochemical SP method to detect CA125 and Ki67 expression in 58 cases of ovarian epithelial carcinoma,electricity chemiluminescence to detect serum CA125 level.Results The positive rate of CA125 in ovary pulp breast cancer,ovarian mucous carcinoma,clear cell carcinoma and endometrial carcinoma were 84.62%,33.33%,66.67% and 71.43% respectively.The positive rate of CA125 in ovary pulp breast cancer was the highest,the lowest in mucous carcinoma,with statistically significant difference (P < 0.01).The positive rate of CA125 in moderately and poorly differentiated epithelial ovarian cancer was higher than that in well differentiated epithelial ovarian cancer (80.00% vs.53.85%),without statistically significant difference (P > 0.05).The positive rate of CA125 in advanced (Ⅲ-Ⅳ) patients was significantly higher than that in early phase (Ⅰ-Ⅱ) patients (85.71% vs.56.52%; P < 0.05).The high expression rate of Ki67 in ovary pulp breast cancer,ovarian mucous carcinoma,clear cell carcinoma and endometrial carcinona were 76.92%,77.78%,100% and 71.43% respectively,without statistically significant difference between them (P > 0.05).The high expression rate of Ki67 in moderately and poorly differentiated epithelial ovarian cancer was significantly higher than that in well differeutiated epithelial ovarian cancer (86.67% vs.46.15%; P < 0.01).The high expression rate of Ki67 in advanced (Ⅲ-Ⅳ) patients was significantly higher than that in early phase (Ⅰ-Ⅱ) patients (88.57% vs.60.87%; P < 0.05).The expression of CA125 and Ki67 in ovarian pulp breast cancer tissue were positively correlated (P < 0.01).The serum CA125 level and the expression of CA125 and Ki67 in ovarian pulp breast cancer tissue were positively correlated (P < 0.05).Conclusions CA125 and Ki67 are closely related to differentiation,classification,transfer of ovarian epithelial carcinoma.The level of serum CA 125 is closely associated with CA125 and Ki67 expression in ovarian pulp breast cancer tissue.Joint detection of CA125 and Ki67 expression level and the concentration of serum CA125 is more helpful to evaluation of the malignant degree,metastasis and other biological behaviors,prognosis than separate detection.